Dare Bioscience Inc
DARE
Get informed when a big investor buys or sells
+ FollowMarket Cap$21.23M
Close$
$0.16
92% downside
Current Fair Value
92% downsideOvervalued by 92% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $21.23 Million |
|---|---|
| Enterprise Value | $4.33 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.2 |
| Beta | 1.09 |
| Outstanding Shares | 14,522,835 |
Return
| Return on Equity | -1636.71% |
|---|---|
| Return on Assets | -43.20% |
| Return on Invested Capital | -185.59% |
Valuation & Multiples
| P/E Ratio | -2.69 |
|---|---|
| PEG | 8.56 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.74 |
| Enterprise Value to EBIT | -0.35 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.37 |
| Debt to Equity | 2.2 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.33
Average shareholder expectationRevenue Estimate
$27,000
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.33
Average shareholder expectationRevenue Estimate
$1,667
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 7.07%▼ 0.66% |
|---|---|
| Total Invested | $1.87M▼ 1.96% |
| Investors Holding | 24▼ 3.00% |
ESG Score
No data